See more : Ooma, Inc. (OOMA) Income Statement Analysis – Financial Results
Complete financial analysis of Optomed Oyj (OPTOMED.HE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Optomed Oyj, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- X1 Entertainment Group Inc. (XOEEF) Income Statement Analysis – Financial Results
- Astrocast SA (ASROF) Income Statement Analysis – Financial Results
- XGD Inc. (300130.SZ) Income Statement Analysis – Financial Results
- Shin Heung Energy & Electronics Co.,Ltd. (243840.KQ) Income Statement Analysis – Financial Results
- AEON Stores (Hong Kong) Co., Limited (0984.HK) Income Statement Analysis – Financial Results
Optomed Oyj (OPTOMED.HE)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.optomed.com
About Optomed Oyj
Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Polaris, and Optomed Halo brands, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, an automated diabetic retinopathy screening service; and Avenue Sync, a software solution for integrating fundus camera to the hospital image archive and worklist server. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system optimized for use by high production healthcare providers; Optomed Service Portal, a support function for healthcare units that order and produce imaging services; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, a digital pathology solution, which allows scanned glass slides to be distributed and diagnosed. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was incorporated in 2004 and is headquartered in Oulu, Finland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 15.10M | 14.66M | 14.85M | 13.01M | 14.98M | 14.46M | 6.90M | 6.61M |
Cost of Revenue | 4.86M | 5.45M | 5.10M | 4.21M | 5.29M | 4.95M | 3.12M | 2.99M |
Gross Profit | 10.24M | 9.21M | 9.75M | 8.80M | 9.69M | 9.51M | 3.78M | 3.62M |
Gross Profit Ratio | 67.83% | 62.84% | 65.64% | 67.62% | 64.71% | 65.75% | 54.81% | 54.76% |
Research & Development | 2.95M | 361.00K | 412.00K | 276.00K | 356.00K | 1.07M | 227.00K | 532.00K |
General & Administrative | 2.51M | 765.00K | 866.00K | 714.00K | 504.00K | 1.65M | 220.00K | 251.00K |
Selling & Marketing | 635.00K | 784.00K | 674.00K | 422.00K | 489.00K | 509.00K | 647.00K | 648.00K |
SG&A | 3.14M | 1.55M | 1.54M | 1.14M | 993.00K | 2.16M | 867.00K | 899.00K |
Other Expenses | 8.13M | 11.97M | 12.17M | 10.13M | 10.55M | 10.17M | 5.52M | 4.82M |
Operating Expenses | 14.22M | 13.88M | 14.12M | 11.54M | 11.90M | 10.17M | 6.61M | 6.25M |
Cost & Expenses | 19.07M | 19.33M | 19.22M | 15.76M | 17.19M | 15.13M | 9.73M | 9.24M |
Interest Income | 23.00K | 4.00K | 17.00K | 8.00K | 3.00K | 38.00K | 2.00K | 6.00K |
Interest Expense | 288.00K | 115.00K | 101.00K | 171.00K | 374.00K | 594.00K | 197.00K | 89.00K |
Depreciation & Amortization | 2.19M | 1.21M | 1.26M | 2.17M | 1.41M | 1.11M | 1.04M | 746.00K |
EBITDA | -2.12M | -4.08M | -2.91M | -281.00K | -1.17M | 376.00K | -1.65M | -1.91M |
EBITDA Ratio | -14.05% | -8.53% | -6.51% | -5.71% | -2.12% | 9.49% | -23.92% | -28.82% |
Operating Income | -3.97M | -4.67M | -4.37M | -2.75M | -2.21M | -665.00K | -2.83M | -2.61M |
Operating Income Ratio | -26.32% | -31.86% | -29.44% | -21.10% | -14.76% | -4.60% | -40.98% | -39.51% |
Total Other Income/Expenses | -545.00K | -880.00K | 45.00K | -341.00K | -356.00K | -555.00K | -63.00K | -151.00K |
Income Before Tax | -4.52M | -5.55M | -4.33M | -3.25M | -2.95M | -1.22M | -2.89M | -2.76M |
Income Before Tax Ratio | -29.93% | -37.86% | -29.14% | -24.96% | -19.71% | -8.44% | -41.89% | -41.79% |
Income Tax Expense | -78.00K | -79.00K | -78.00K | -70.00K | -77.00K | 48.00K | -3.00K | -3.00K |
Net Income | -4.44M | -5.47M | -4.25M | -3.18M | -2.88M | -1.27M | -2.89M | -2.76M |
Net Income Ratio | -29.41% | -37.33% | -28.61% | -24.42% | -19.20% | -8.77% | -41.85% | -41.73% |
EPS | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.10 | -0.22 | -0.21 |
EPS Diluted | -0.27 | -0.37 | -0.32 | -0.24 | -0.32 | -0.10 | -0.22 | -0.21 |
Weighted Avg Shares Out | 16.71M | 14.64M | 13.44M | 13.26M | 8.94M | 13.19M | 13.19M | 13.19M |
Weighted Avg Shares Out (Dil) | 16.71M | 14.64M | 13.44M | 13.26M | 8.94M | 13.19M | 13.19M | 13.19M |
Source: https://incomestatements.info
Category: Stock Reports